Documente Academic
Documente Profesional
Documente Cultură
Muhammad Jalal, Eric Montgomery, Ismerai Rodriguez, EJ Crane, and Katy Muzikar
ABSTRACT
Green fluorescent protein (GFP) is an important
tool in a number of biochemical and molecular
biology contexts, such as protein expression and
localization, thanks to its characteristic
fluorescence. Driven by an excited state proton
transfer system which excites a chromophore
embedded in the protein, GFP is tightly protected
from outside forces through a beta barrel structure.
A number of amino acid mutations have been
developed to enhance the fluorescence and
stability of GFP, such as enhanced green fluorescent
protein (EGFP), though most research focuses on
Figure 1. Interacting residues in GFP. The chromophore,
residues immediately surrounding the
located in the center of the picture, interacts through
chromophore. In this paper, we investigate the hydrogen bonds with a number of surrounding residues,
effects mutagenesis of V163 in EGFP, a non- indicated by their number. This is suggested to be the
interacting residue, through mutations V163A and mechanism through which fluorescence emerges. Of
V163G. Our findings suggest that both mutants particular importance is Q183 (orange), said to interact
with V163. Image obtained from Brejk et al. (1997).
have an increase in fluorescence compared to WT,
though not to the degree indicated by past studies. Due to the experimental importance of
GFP, it has become a priority to create mutants
INTRODUCTION with enhanced properties. Point mutations of
the protein have led to the development of
The discovery of Green Fluorescent Protein, variants with greater fluorescence, alternative
originally isolated from Aequores victoria, has color emission, and increased stability. A widely
led to a remarkable breakthrough in used variant, termed Enhanced Green
investigations of localization and gene Fluorescent Protein (EGFP), involves a mutation
expression within cellular and molecular biology with a chromophore encoding residue and has
systems. The 238 amino-acid encoding protein been shown to exhibit 3.3 times greater
obtains its fluorescent and spectroscopic fluorescence than wild-type GFP.3 Other variants
properties from a conjugated -electron exploit the hydrogen bonding network through
resonance system formed by the oxidation of mutations of chromophore-surrounding
the tripeptide chromophore Tyr65-Thr66- residues, which may be a contributor for both
Gly67.1 An excited state proton transfer stability and fluorescence.
mechanism, involving the hydrogen bond Less clear is the importance of residues
interactions of neighboring amino acid residues more distant from the chromophore. An
and the chromophore, has been suggested to interiorly located residue, V163 has been
contribute to the intensity of fluorescence and targeted in a number of successful mutants. A
the stability of the protein (Figure 1).2 The V163A mutation of EGFP resulted in a 2.7-fold
chromophore is imbedded within the interior of increase in fluorescence.3 Performing this
a hydrophobic beta barrel, which protects it mutation in GFP alongside F99S and M153T,
from quenching by polar molecules. other residues that are distant from the
Figure 2. PyMOL generated images showing mutagenesis of V163A and V163G. (A) The wild-type configuration. V163 (pink) is
located in the interior of the protein, though it does not interact with the chromophore. (B) A potential rotamer of the V163A
mutation. The side chain (pink) decreases, but the protein still points inward. (C) A potential rotamer of the V163G mutation.
Because of the loss of a carbon side chain (pink), the protein no longer points primarily inward.
Kinetics of renaturation were determined using Figure 3. Gel electrophoresis of PCR product (V163 lane)
confirms the presence of a 6000 bp product. For reference,
the total degree of fluorescence increase from
the length of the p28a_EGFP2 plasmid is 6050 bp.
the initial and final reading, and creating a ratio
evaluating specific increase after each time
Mini-prep Product Purity
point. The data was fitted to a polynomial Following inoculation and purification, the
equation using Excel.
concentration and purity (using the A260/A280
value) of the obtained plasmid was assessed
RESULTS using a Nanodrop Spectrophotometer (Table 4).
Confirmation of Product by Gel Electrophoresis
To confirm the presence of a highly amplified Table 4. Nanodrop Results for Combined Colony Mini-
product, a sample of the completed PCR prep
reaction was loaded and analyzed through gel Concentration A260/A280
electrophoresis. A product of approximately
447.5 ng/ L 1.87
6000 bp was present in the reaction,
corresponding closely with the length of the
6050 bp p28a_EGFP2 plasmid (Figure 3). Sequencing Analysis
After a new colony was picked and purified
Transformation of V163G EGFP through a mini-prep kit, the DNA was sequenced
Following heat-shock transformation of XL-10 using the Sanger method to confirm the
Gold cells and overnight incubation, 150 presence of the desired mutation (Figure 4). The
colonies were counted on the LB-Kanamycin resulting DNA sequence was analyzed against
plate. Two colonies were inoculated to confirm EGFP and V163A using CLC viewer (Figure 4A).
transformation and to amplify the desired The triple codon containing the blue codon in
plasmid. the middle reflected the amino acid.
Figure 4. Sanger Sequencing analysis of single colony mini-prep reveals successful mutagenesis. (A) Alignment analysis using CLC
viewer of EGFP and the reverse compliments of V163A/V163G reveal a single base pair mutation. The triple codon sequences
represented by the blue misalignment, GCT, GGT, and GTT, correspond to alanine, glycine, and valine, respectively. (B)
Chromatogram obtained by Sanger sequencing of V163A and V163G.
Figure 5. SDS-PAGE Gel of Protein Fractions confirms purification of a ~27 kDA protein, matching the literature value weight of
EGFP. (A) Gel images of the V163A mutation. T= corresponds to the various hourly induction points isolated from protein
induction, Crude corresponds to the crude supernatant obtained prior to affinity purification, FT corresponds flow through, M1-
M3 correspond to the mutant EGFP fractions obtained following saturation via elution buffer, and WT1-3 correspond to the wild-
type EGFP fractions obtained similarly. (B) Gel images of the V163G mutation. Notation of the gel is identical to the above.
Table 6. Fluorescent properties of EGFP variants. Kinetics of fluorescence were derived using the
Relative Emission Excitation ratio of fluorescence recovery at each point to
Fluorescence Wavelength Wavelength the total degree of recovery over the 6 or 7
(nm) (nm)
minutes (Figure 10). Through polynomial curve
WT 1 511 489
fitting, more fluorescence of V163A was
V163A 1.7 513 490 recovered at early time points than of the other
V163G 1.5 513 489 variants.
Figure 7. Fluorimetric data of EGFP variants. Dotted lines indicate emission spectra (510 nm), and solid lines indicate excitation
spectra (490 nm). Mutant variants have higher relative fluorescence than wild type EGFP.
Figure 8. Fluorimetric data of thermal denaturation in EGFP variants shows full extinction of fluorescence at 95C in WT and
V163G. Different colored curves reflect different temperatures (as indicated by the legend on the right of each chart). Peaks
reflect emission patterns following an excitation wavelength of 490 nm. (A) WT EGFP. (B) V163A (C) V163G.
Figure 9. Fluorimetric data of thermal renaturation in EGFP variant shows full recovery for V163A and WT following exposure to
denaturation at 65C. Different colored curves reflect different time points (as indicated by the legend on the right of each chart).
Peaks reflect emission patterns following an excitation wavelength of 490 nm. (A) WT EGFP. (B) V163A (C) V163G.
80
60
40
20
0
1 2 3 4 5 6
TIME POINT (MINUTE)
Figure 10. Kinetic assessment of fluorescence recovery after each minute of incubation at 25C shows V163A regenerates
fluorescence faster. Bar graphs indicate cumulative increases in fluorescence after each minute. Dotted curve shows a fitted
polynomial curve for the degree of recovery for each variant.